The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 11,500.00
Ask: 12,200.00
Change: 0.00 (0.00%)
Spread: 700.00 (6.087%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-Sterling edges up vs euro on Brexit optimism; short positions reduced

Mon, 26th Oct 2020 12:28

* Graphic: World FX rates in 2020 http://tmsnrt.rs/2egbfVh

* Graphic: Trade-weighted sterling since Brexit vote http://tmsnrt.rs/2hwV9Hv
(Updates prices, adds comment)

By Elizabeth Howcroft

LONDON, Oct 26 (Reuters) - Cautious currency markets kept
the pound subdued against a stronger dollar on Monday, but
sterling strengthened against the euro as the current phase of
Brexit negotiations was extended until Wednesday.

The dollar strengthened, equities fell, and markets were
broadly risk-off. Analysts cited new lockdowns in Europe and
record-high daily virus cases in the United States, as well as a
lack of progress towards U.S. fiscal stimulus.

But the pound took some support from signs of progress in
Brexit trade talks. The EU's chief negotiator, Michel Barnier,
will be in London until Wednesday to try and clinch a deal,
after which negotiations will switch to Brussels.

"Right now there’s a bit of optimism creeping in from the
weekend developments - the extension of the talks until
Wednesday," said Ned Rumpeltin, head of European currency
strategy at TD Securities.

"The fact that France might be signalling some movement on
fish is encouraging. We’ll see how that plays out," he said.

At 1051 GMT, the pound was little changed against the
dollar, at $1.3051. It was up around 0.4% against the
euro, at 90.58 pence.

Britain and the EU have just over two months left to agree
on their future trading relationship, before a Dec. 31 deadline.

There are some hopes that a Brexit deal can be reached, with
Ireland's Deputy Prime Minister and Northern Ireland minister
Brandon Lewis expressing optimism on Sunday.

Asked about reports that the UK was waiting to see the
result of the U.S. elections before making a decision about
Brexit, Prime Minister Boris Johnson said the two were "entirely
separate".

Goldman Sachs FX strategists said that Brexit developments
were looking positive.

"Despite sterling's underperformance on Friday, we continue
to see a path for a sharply higher GBP/USD cross into year-end,"
they wrote in a note.

Speculators reduced their net short position on the pound in
the week to Oct. 20, for the third week running, weekly CFTC
futures data showed.

TD Securities' Rumpeltin said that this could be due to a
combination of market participants reining in positioning before
the U.S. election and that the range of possibilities around
Brexit are narrowing.

Elsewhere, news that a vaccine being developed by British
drugmaker AstraZeneca and the University of Oxford
produced an immune response in elderly and young people failed
to bolster market sentiment.

Britain's health minister said his central expectation was
for a vaccine to be rolled out for the first half of 2021.
(Reporting by Elizabeth Howcroft; editing by Emelia
Sithole-Matarise, Larry King)

More News
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more
27 Dec 2023 14:25

London close: Stocks maintain gains amid post-Christmas rally

(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.

Read more
27 Dec 2023 12:06

LONDON MARKET MIDDAY: Stocks hold onto gains amid US rate cut hopes

(Alliance News) - London's FTSE 100 index was outperforming other European stock-price measures at midday on Wednesday, boosted by gains for miners and industrials.

Read more
27 Dec 2023 11:20

London midday: Stocks ride global wave of post-Christmas optimism

(Sharecast News) - London's equity markets were still above the waterline at lunchtime on Wednesday, following a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:48

LONDON MARKET OPEN: FTSE 100 gains led by miners and industrials

(Alliance News) - Stock prices in London opened in the green on Wednesday, as hopes for US interest rate cuts in the new year continued to propel global equities higher.

Read more
27 Dec 2023 08:26

London open: FTSE takes cues from Wall Street 'Santa rally'

(Sharecast News) - London's stocks returned from the Christmas break in the green on Wednesday, boosted by a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:24

TOP NEWS: AstraZeneca buys Gracell to "enrich" cell therapy pipeline

(Alliance News) - AstraZeneca PLC on Tuesday said it has agreed to acquire Gracell Biotechnologies Inc, paying about USD1.2 billion for the clinical-stage company.

Read more
27 Dec 2023 07:52

LONDON BRIEFING: AstraZeneca buys Gracell Biotech; COPL CEO resigns

(Alliance News) - Stocks in London were expected to make gains at Wednesday's market open, as investors continued to pin their hopes on US interest rate cuts.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.